Data as of Mar 14
| -0.11 / -6.08%|
The 2 analysts offering 12-month price forecasts for Aveo Pharmaceuticals Inc have a median target of 1.50, with a high estimate of 2.00 and a low estimate of 1.00. The median estimate represents a -11.76% decrease from the last price of 1.70.
The current consensus among 4 polled investment analysts is to Hold stock in Aveo Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.